P2RY12
MOLECULAR TARGETpurinergic receptor P2Y12
P2RY12 (purinergic receptor P2Y12) is targeted by 9 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting P2RY12
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | clopidogrel | 3.66 | 38 |
| 2 | Ticagrelor | 2.71 | 14 |
| 3 | rb 2 | 2.40 | 10 |
| 4 | cangrelor | 2.30 | 9 |
| 5 | acid blue 25 | 2.20 | 8 |
| 6 | Adenosine Diphosphate Adenosine 5'-(trihydrogen diphosphate). | 1.39 | 3 |
| 7 | Adenosine Triphosphate | 0.69 | 1 |
| 8 | Leukotriene E4 | 0.69 | 1 |
| 9 | Suramin | 0.69 | 1 |
About P2RY12 as a Drug Target
P2RY12 (purinergic receptor P2Y12) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 9 compounds with documented P2RY12 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
P2RY12 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.